比较图式治疗与常规治疗对难治性抑郁症门诊患者的平行组随机临床试验的统计分析计划(DEPRE-ST)
DEPRE-ST是一项随机多中心平行组优效性临床试验,计划纳入129例难治性抑郁症门诊患者,随机接受30次个体图式治疗或常规心理治疗联合精神药物治疗,主要结局为12个月时抑郁症状(汉密尔顿抑郁评定量表6项版),该统计分析计划在数据揭盲前制定并提交。
要点
- DEPRE-ST试验比较图式治疗与常规治疗对难治性抑郁症的疗效与危害。
- 主要结局为12个月时汉密尔顿抑郁评定量表6项版评估的抑郁症状。
- 统计分析计划在数据揭盲前制定并提交以确保透明度并减少偏倚。
核心结论
- 该统计分析计划在数据揭盲前制定并提交,以确保透明度并减少结果选择、分析和报告中的偏倚。
研究设计与样本
- 随机多中心平行组优效性临床试验,计划随机化129例患者接受30次个体图式治疗或常规心理治疗,均联合精神药物治疗。
- 在随机化前及随机化后6、12、24个月进行评估,主要结局评估者、统计学家和数据安全与监督委员会设盲。
关键数值与推荐
- 主要结局为12个月时汉密尔顿抑郁评定量表6项版评估的抑郁症状,采用多水平线性回归分析,对缺失数据采用保守的多重插补,并以协变量校正的组间变化值差异及其95%置信区间呈现。
- 次要结局包括健康相关生活质量(欧洲五维五水平量表)、功能损害(工作与社会适应量表)、心理幸福感(WHO-5幸福感指数)和治疗负性效应(负性效应问卷),以及一系列患者相关的探索性结局。
- 将进行健康经济学分析。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: "Difficult-to-treat" depression - here operationalized as either chronic or treatment-resistant depression - encompasses about one third of all patients with depression. Despite its considerable size, the patient group is understudied, and evidence-based psychotherapeutic treatment options are currently limited. The DEPRE-ST trial therefore seeks to investigate beneficial and harmful effects of schema therapy for difficult-to-treat depression. METHODS: This is a randomized multicenter parallel-group superiority clinical trial. A total of 129 patients will be randomized to receive either 30 sessions of individual schema therapy or psychotherapy according to Treatment As Usual, along with psychopharmacological treatment. Participants are assessed before randomization and at 6, 12, and 24 months after randomization. The primary outcome is depression symptoms (6-item Hamilton Rating Scale for Depression), assessed at 12 months. Secondary outcomes include health-related quality of life (European Quality of Life 5 Dimensions 5 Level Version), functional impairment (Work and Social Adjustment Scale), psychological wellbeing (WHO-5 Well-being Index), and negative effects of treatment (Negative Effects Questionnaire), alongside a range of patient-relevant exploratory outcomes. Blinding of treatment allocation is ensured for primary outcome assessors, statisticians, and the data safety and monitoring committee. The primary outcome will be analyzed with multilevel linear regression, with conservative multiple imputation for missing data, and presented as the covariate-adjusted difference between treatments' change scores with its 95% confidence intervals. Further, a health economic analysis will be performed. DISCUSSION: This statistical analysis plan was developed and submitted before unblinding of data to ensure transparency and diminish bias in selection, analysis, and reporting of results. TRIAL REGISTRATION: ClinicalTrials.gov NCT05833087. Registered on 15th April 2023. https://clinicaltrials.gov/study/NCT05833087?term=depre-st&checkSpell=false&rank=1.
引用
- Arendt ITP, Gondan M, Juul S, et al. Statistical analysis plan for a parallel group randomized clinical trial comparing schema therapy versus treatment as usual for outpatients with difficult-to-treat depression (DEPRE-ST). Trials. 2025. PMID: 40890784. doi:10.1186/s13063-025-09012-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。